The current study indicated that Plin4, Sgk1, Klf2 and Dcaf12l1 were differentially expressed in depression models treated with ketamine, phencyclidine and memantine, which suggested that these genes may be the targets of the NMDA receptor antagonist treatment. Here, KLF2 is linked to depressive symptom measurement.